Department of Microbiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute, Melbourne, Victoria, Australia.
Specialist Ad-Hoc Research Ethics Committee for COVID-19 Human Challenge Studies, Health Research Authority, London, UK.
Vaccine. 2022 Jun 9;40(26):3484-3489. doi: 10.1016/j.vaccine.2022.02.004. Epub 2022 Feb 14.
This report of a joint World Health Organization (WHO) and United Kingdom (UK) Health Research Authority (HRA) workshop discusses the ethics review of the first COVID-19 human challenge studies, undertaken in the midst of the pandemic. It reviews the early efforts of international and national institutions to define the ethical standards required for COVID-19 human challenge studies and create the frameworks to ensure rigorous and timely review of these studies. This report evaluates the utility of the WHO's international guidance document Key criteria for the ethical acceptability of COVID-19 human challenge studies (WHO Key Criteria) as a practical resource for the ethics review of COVID-19 human challenge studies. It also assesses the UK HRA's approach to these complex ethics reviews, including the formation of a Specialist Ad-Hoc Research Ethics Committee (REC) for COVID-19 Human Challenge Studies to review all current and future COVID-19 human challenge studies. In addition, the report outlines the reflections of REC members and researchers regarding the ethics review process of the first COVID-19 human challenge studies. Finally, it considers the potential ongoing scientific justification for COVID-19 human challenge studies, particularly in relation to next-generation vaccines and optimisation of vaccination schedules. Overall, there was broad agreement that the WHO Key Criteria represented an international consensus document that played a powerful role in setting norms and delineating the necessary conditions for the ethical acceptability of COVID-19 human challenge studies. Workshop members suggested that the WHO Key Criteria could be practically implemented to support researchers and ethics reviewers, including in the training of ethics committee members. In future, a wider audience may be engaged by the original document and potential additional materials, informed by the experiences of those involved in the first COVID-19 human challenge studies outlined in this document.
本报告是世界卫生组织(世卫组织)和联合王国(英国)卫生研究管理局(HRA)联合举办的一次研讨会的报告,讨论了在大流行期间首次进行的 COVID-19 人体挑战研究的伦理审查问题。它审查了国际和国家机构为 COVID-19 人体挑战研究确定所需伦理标准并创建框架以确保对这些研究进行严格和及时审查的早期努力。本报告评估了世卫组织关于 COVID-19 人体挑战研究的伦理可接受性的国际指导文件《COVID-19 人体挑战研究的关键标准》(世卫组织关键标准)作为 COVID-19 人体挑战研究伦理审查实用资源的效用。它还评估了英国 HRA 对这些复杂伦理审查的方法,包括成立一个专门的临时研究伦理委员会(REC)来审查所有当前和未来的 COVID-19 人体挑战研究。此外,该报告概述了 REC 成员和研究人员对首次 COVID-19 人体挑战研究的伦理审查过程的反思。最后,它考虑了 COVID-19 人体挑战研究在未来可能存在的科学依据,特别是在新一代疫苗和优化疫苗接种时间表方面。总体而言,与会者广泛认为,世卫组织关键标准是一份国际共识文件,在为 COVID-19 人体挑战研究的伦理可接受性设定规范和划定必要条件方面发挥了强大作用。研讨会成员建议,可以实际实施世卫组织关键标准来支持研究人员和伦理审查人员,包括对伦理委员会成员进行培训。在未来,可能会有更广泛的受众参与到原始文件和潜在的补充材料中来,这些材料是根据本文件中概述的首次 COVID-19 人体挑战研究参与者的经验提供的。